PARADIGM BIOCAPITAL ADVISORS LP
Adviser information for PARADIGM BIOCAPITAL ADVISORS LP last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Partnership |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 8 |
---|---|
Investment Advisory/Research | 5 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 4 | $2.4B |
Non-Discretionary | 0 | $0 |
Total | 4 | $2.4B |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 3 | $2.0B |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | <5 | $346.9M |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 50 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
767 THIRD AVENUE17TH FLOOR
NEW YORK
NY
United States
Monday - Friday, 9:00 AM - 5:00 PM
Tel: 646-970-2568, Fax: None
Chief Compliance Officer
DAVID KIM
CHIEF OPERATING OFFICER & CHIEF COMPLIANCE OFFICER
767 THIRD AVENUE
17TH FLOOR
NEW YORK
NY
United States
Tel:
646-970-2568
D****@*********************M
(Full email address available in API data)
Industry Affiliates
PARADIGM BIOCAPITAL GP LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
PARADIGM BIOCAPITAL INTERNATIONAL FUND LTD. | Hedge Fund | $2,011.3M | $5.0M | 126 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
ASEFAW, DR. SENAI, NMN | Individual | – | CHIEF INVESTMENT OFFICER / LIMITED PARTNER | 12/2020 | > 75% |
KIM, DAVID, KYUNGTAEK | Individual | – | CHIEF OPERATING OFFICER / CHIEF COMPLIANCE OFFICER | 01/2021 | < 5% |
PARADIGM BIOCAPITAL ADVISORS GP LLC | Domestic Entity | – | GENERAL PARTNER | 12/2020 | < 5% |
ASEFAW, DR. SENAI, NMN | Individual | PARADIGM BIOCAPITAL ADVISORS GP LLC | MANAGING MEMBER | 01/2022 | > 75% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
ACRIVON THERAPEUTICS INC | COMMON STOCK | 4M | 660K | – |
ALX ONCOLOGY HLDGS INC | COM | 10M | 2M | – |
APOGEE THERAPEUTICS INC | COM | 13M | 330K | – |
ARCELLX INC | COMMON STOCK | 212M | 4M | – |
ARGENX SE | SPONSORED ADR | 231M | 538K | – |
ARVINAS INC | COM | 65M | 2M | – |
ASCENDIS PHARMA A/S | SPONSORED ADR | 91M | 664K | – |
BRIDGEBIO PHARMA INC | COM | 28M | 1M | – |
CEREVEL THERAPEUTICS HLDNG I | COM | 95M | 2M | – |
COGENT BIOSCIENCES INC | COM | 31M | 4M | – |
COMPASS PATHWAYS PLC | SPONSORED ADS | 14M | 2M | – |
CRINETICS PHARMACEUTICALS IN | COM | 113M | 3M | – |
CULLINAN THERAPEUTICS INC | COM | 27M | 2M | – |
DISC MEDICINE INC | COM | 122M | 3M | – |
EDGEWISE THERAPEUTICS INC | COM | 42M | 2M | – |
ERASCA INC | COM | 17M | 7M | – |
IMMATICS N.V | SHS | 40M | 3M | – |
IMMUNOVANT INC | COM | 36M | 1M | – |
JANUX THERAPEUTICS INC | COM | 66M | 2M | – |
KURA ONCOLOGY INC | COM | 93M | 5M | – |
LEGEND BIOTECH CORP | SPONSORED ADS | 53M | 1M | – |
MERUS N V | COM | 120M | 2M | – |
NUVALENT INC | COM | 347M | 5M | – |
OLEMA PHARMACEUTICALS INC | COM | 86M | 8M | – |
PERSPECTIVE THERAPEUTICS INC | COM NEW | 9M | 920K | – |
REVOLUTION MEDICINES INC | COM | 204M | 5M | – |
SAREPTA THERAPEUTICS INC | COM | 150M | 948K | – |
TARSUS PHARMACEUTICALS INC | COM | 66M | 2M | – |
TSCAN THERAPEUTICS INC | COM | 2M | 354K | – |
VAXCYTE INC | COM | 47M | 627K | – |
VERONA PHARMA PLC | SPONSORED ADS | 10M | 721K | – |
VIRIDIAN THERAPEUTICS INC | COM | 38M | 3M | – |
VOR BIOPHARMA INC | COM | 6M | 6M | – |
XENON PHARMACEUTICALS INC | COM | 80M | 2M | – |
Y-MABS THERAPEUTICS INC | COM | 47M | 4M | – |